おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Trinds
company
About
Trinds is a new contract research organization
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Industries
- Market Research
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS) is a specialized contract research organization (CRO).
They are a team of clinical trial specialists with focused expertise in neuromuscular and rare disease. They have 15+ years of experience in successful academic and pharma-sponsored clinical trials research and drug development programs. Their goals are centered around our clients and the patient community. Together their team has successfully set-up, run and completed key clinical trial programs. They provide four key areas of support to pharmaceutical, biotechnology industries, and academic investigators and clinical trial sites.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Trinds has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2016 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2016 | Series Unknown | — | 1 |
CureDuchenne Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Trinds is funded by 1 investors.
CureDuchenne Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
CureDuchenne Ventures
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
